Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Gout
ADR ID BADD_A01871
ADR Hierarchy
14      Metabolism and nutrition disorders
14.09      Purine and pyrimidine metabolism disorders
14.09.01      Disorders of purine metabolism
14.09.01.001      Gout
15      Musculoskeletal and connective tissue disorders
15.01      Joint disorders
15.01.06      Crystal arthropathic disorders
15.01.06.001      Gout
Description Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. [MeSH]
MedDRA Code 10018627
MeSH ID D006073
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Articular gout | Gout | Gout acute | Gout aggravated | Gout with other manifestations | Gout with other specified manifestation | Gout with other specified manifestations | Gout, unspecified | Podagra | Retrocedent gout | Secondary gout | Gout flare | Gout attack | Gouty pain | Refractory gout | Gouts
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02375Water--
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02392Zoledronic acid0.004294%
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02407Upadacitinib--
BADD_D02412Octreotide0.000373%
BADD_D02436Atorvastatin--
BADD_D02443Tiotropium0.000126%
BADD_D02452Icatibant-
BADD_D02470Nintedanib0.000492%
BADD_D02487Baricitinib0.000820%
BADD_D02500Alpelisib0.000381%
BADD_D02504Lorlatinib0.000112%
BADD_D02515Pexidartinib0.000761%
BADD_D02517Enasidenib0.000246%
BADD_D02533Bempedoic acid0.000338%
BADD_D02554Fedratinib0.000246%
BADD_D02580Ozanimod0.000820%
BADD_D02608Voclosporin0.000651%
The 9th Page    First    Pre   9    Total 9 Pages